The Maplewood, MN-based company posted “disappointing” 1Q19 earnings and lowered its 2019 outlook.
Business - News
Yokneam, Israel-based Rapid Medical has raised $20 million in a series C round and will use the proceeds to help complete its IDE study.
FDA’s approval of BAROnova’s TransPyloric Shuttle device comes during a time of significant shifts and changes in the obesity treatment market.
Large retailers are planting their flags in healthcare with Amazon and Best Buy leading the charge to get into the market.
The Sunnyvale, CA-based company has long been the top dog in surgical robotics but increased competition is right around the corner for the firm.
Seeing firsthand the limitations of current overactive bladder therapies, a urogynecology surgeon invented a wearable, non-surgical solution to the problem.
The Abbott Park, IL-based has had a solid foundation of success dating back to the closure of the St. Jude Medical acquisition.
Results from the prospective, randomized, controlled, multi-surgeon clinical trial were published in Ophthalmology Glaucoma.
Johnson & Johnson’s earnings might have been down 14% when compared to last year, but the New Brunswick, NJ-based company was still able to beat analysts’ expectations.
Researchers at James Cook University in Australia found that material commonly used for fish allergy testing is unreliable.
The move comes about a week after the San Diego-based company revealed it would cut 50% of its workforce.
Solana Beach, CA-based Puregraft has developed a technology that would use a person’s own fat for breast augmentation or restructuring.